Assignee

Achillion Pharmaceuticals, Inc.

Patents = 102

Trademarks = 5

Forward Citations = 990

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

48 inventors (with patents filed for the assignee):

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare diseases. We are dedicated to transforming the care of patients with complement-mediated diseases through our expertise in the complement system, a vital part of the immune system. Our pipeline includes potential treatments for diseases such as paroxysmal nocturnal hemoglobinuria (PNH), C3 glomerulopathy (C3G), and immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN).

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com